The implementation of Solvency 2 Directive, which will come into force in 2016, in the insurance industry does not seem to lead to a radical change in the innovation product process. On the contrary it will produce more relevant consequences in the internal processes of the companies, in particular Organization and It, especially for the assessment and management of financial and insurance risks
